Letter in response to "Idarucizumab for dabigatran overdose"
Clin Toxicol (Phila)
.
2017 Jan;55(1):65.
doi: 10.1080/15563650.2016.1240804.
Epub 2016 Oct 6.
Authors
Josh J Wang
1
,
Eric Villeneuve
2
,
Sophie Gosselin
3
4
Affiliations
1
a Emergency Medicine Residency program , McGill University , Montreal , Canada.
2
b Department of Pharmacy , McGill University Health Centre , Montreal , Canada.
3
c Centre Antipoison du Quebec , Quebec , Canada.
4
d Departments of Medicine and Emergency Medicine , McGill University Health Centre , Montreal , Canada.
PMID:
27710136
DOI:
10.1080/15563650.2016.1240804
No abstract available
Publication types
Comment
MeSH terms
Antithrombins / therapeutic use*
Dabigatran*
Drug Overdose / drug therapy
Humans
Substances
Antithrombins
Dabigatran